{
  "resourceType" : "MedicationStatement",
  "id" : "MII-EXA-MTB-Systemische-Therapie-Medication-4",
  "meta" : {
    "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemtherapie-medication-statement",
    "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.1"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement MII-EXA-MTB-Systemische-Therapie-Medication-4</b></p><a name=\"MII-EXA-MTB-Systemische-Therapie-Medication-4\"> </a><a name=\"hcMII-EXA-MTB-Systemische-Therapie-Medication-4\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profiles: <a href=\"StructureDefinition-mii-pr-mtb-systemtherapie-medication-statement.html\">MII PR MTB Systemtherapie Medication Statement</a>, <a href=\"https://simplifier.net/resolve?scope=de.basisprofil.r4@1.5.4&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.1\">https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.1</a></p></div><p><b>basedOn</b>: <a href=\"MedicationRequest-mii-exa-mtb-medication-request-mirvetuximab.html\">MedicationRequest: extension = 1,m1A,http://doi.org#10.1200/JCO.2022.40.16_suppl.5512,http://www.ncbi.nlm.nih.gov/pubmed#38055253; status = completed; intent = proposal; medication[x] = MIRVETUXIMAB SORAVTANSINE; authoredOn = 2023-03-28</a></p><p><b>partOf</b>: <a href=\"Procedure-MII-EXA-MTB-Systemische-Therapie-1.html\">Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie</a></p><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:{http://fdasis.nlm.nih.gov 98DE7VN88D}, {http://fhir.de/CodeSystem/bfarm/atc L01FX26}\">MIRVETUXIMAB SORAVTANSINE</span></p><p><b>subject</b>: <a href=\"Patient-PatientKimMusterperson.html\">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>effective</b>: 2023-08-29 --&gt; 2023-08-29</p><p><b>note</b>: </p><blockquote><div><p>29.08.2023 Z4 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22</p>\n</div></blockquote><blockquote><p><b>dosage</b></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>6 mg/kg KG<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codemg/kg{KG} = 'mg/kg{KG}')</span></td></tr></table></blockquote></div>"
  },
  "basedOn" : [{
    "reference" : "MedicationRequest/mii-exa-mtb-medication-request-mirvetuximab"
  }],
  "partOf" : [{
    "reference" : "Procedure/MII-EXA-MTB-Systemische-Therapie-1"
  }],
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [{
      "system" : "http://fdasis.nlm.nih.gov",
      "code" : "98DE7VN88D",
      "display" : "MIRVETUXIMAB SORAVTANSINE"
    },
    {
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "version" : "2025",
      "code" : "L01FX26",
      "display" : "Mirvetuximab soravtansin"
    }]
  },
  "subject" : {
    "reference" : "Patient/PatientKimMusterperson"
  },
  "effectivePeriod" : {
    "start" : "2023-08-29",
    "end" : "2023-08-29"
  },
  "note" : [{
    "text" : "29.08.2023 Z4 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22"
  }],
  "dosage" : [{
    "doseAndRate" : [{
      "doseQuantity" : {
        "value" : 6,
        "unit" : "mg/kg KG",
        "system" : "http://unitsofmeasure.org",
        "code" : "mg/kg{KG}"
      }
    }]
  }]
}